A Phase II Clinical Trial of Neoadjuvant Chemotherapy With M-VAC Plus Avastin in Patients With Locally Advanced Urothelial Cancer.

Trial Profile

A Phase II Clinical Trial of Neoadjuvant Chemotherapy With M-VAC Plus Avastin in Patients With Locally Advanced Urothelial Cancer.

Completed
Phase of Trial: Phase II

Latest Information Update: 02 Apr 2016

At a glance

  • Drugs Bevacizumab (Primary) ; Cisplatin; Doxorubicin; Methotrexate; Vinblastine
  • Indications Urogenital cancer
  • Focus Biomarker; Therapeutic Use
  • Most Recent Events

    • 02 Jun 2015 Final results presented at the 51st Annual Meeting of the American Society of Clinical Oncology.
    • 26 Aug 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
    • 21 Jan 2014 Planned End Date changed from 1 Jun 2014 to 1 Jun 2015 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top